Plexiform Neurofibroma: Clinical Trials

3 trials for Plexiform Neurofibroma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow Plexiform Neurofibroma: new trials by email Literature Review of Plexiform Neurofibroma trials Research Report on Plexiform Neurofibroma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Avutometinib for People With Solid Tumor Cancers
Avutometinib - Refractory Cancer, CNS Tumors
Phase 1CompletedMemorial Sloan Kettering Cancer Center32023-10-202026-11-04
Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours
Selumetinib - Neurofibromatosis Type 1, Plexiform Neurofibroma
Phase 1 / Phase 2CompletedGreat Ormond Street Hospital for Children NHS Foundation Trust142019-09-262024-04-04
Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
Nexavar (BAY 43-9006) (Sorafenib), Toxicity, Pharmacokinetics, Pharmacodynamics - Neurofibromatosis Type I, Plexiform Neurofibroma
Phase 1CompletedNational Cancer Institute (NCI)92008-07-082019-12-12

Narrower conditions

Neurofibroma, Plexiform (3)  ·  Neurofibromatosis 1 (2)  ·  Brain Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Neoplasms (1)  ·  Neuroblastoma (1)  ·  Optic Nerve Glioma (1)

Broader conditions

Neoplasms by Histologic Type (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Nerve Sheath Neoplasms (3)  ·  Nervous System Diseases (3)  ·  Nervous System Neoplasms (3)  ·  Neurofibroma (3)  ·  Neuromuscular Diseases (3)  ·  Peripheral Nervous System Diseases (3)  ·  Peripheral Nervous System Neoplasms (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Heredodegenerative Disorders, Nervous System (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)

Interventions

AZD 6244 (1)  ·  Pharmacokinetics (1)  ·  Sorafenib (1)

Sponsors

Great Ormond Street Hospital for Children NHS Foundation Trust (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  United Kingdom (1)

Top investigators

Brigitte C Widemann, M.D. (1)  ·  Darren Hargrave, MB Bch (1)  ·  Sameer Farouk Sait, MD (1)